sensus_logo.jpg
Sensus Healthcare Reports Third Quarter 2023 Financial Results
09 nov. 2023 16h05 HE | Sensus Healthcare, Inc.
   Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sensus...
sensus_logo.jpg
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
02 nov. 2023 08h00 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...
sensus_logo.jpg
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
09 oct. 2023 08h00 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
sensus_logo.jpg
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
28 sept. 2023 08h30 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla. , Sept. 28, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
sensus_logo.jpg
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
26 sept. 2023 08h00 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
sensus_logo.jpg
Sensus Healthcare Announces New $3 Million Share Repurchase Program
08 août 2023 08h30 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
sensus_logo.jpg
Sensus Healthcare Reports Second Quarter 2023 Financial Results
03 août 2023 16h05 HE | Sensus Healthcare, Inc.
Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at...
sensus_logo.jpg
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
26 juil. 2023 08h30 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla., July 26, 2023 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological...
sensus_logo.jpg
Sensus Healthcare Completes Installation of its First SRT System in Ireland
25 juil. 2023 08h30 HE | Sensus Healthcare, Inc.
Delivery of the SRT-100 marks the expansion of radiotherapy services at Dublin’s Beacon Hospital Non-melanoma skin cancer affects more than 12,000 patients in Ireland annually BOCA RATON, Fla.,...
sensus_logo.jpg
Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
06 juil. 2023 16h05 HE | Sensus Healthcare, Inc.
BOCA RATON, Fla, July 06, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...